AI could help doctors treat breathing failure more precisely

NCT ID NCT06479421

Recruiting now Knowledge-focused Sponsor: Samsung Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is collecting data from 250 patients with acute respiratory failure to develop an AI model that groups patients by their characteristics. The goal is to personalize treatment and improve outcomes. It is an observational study, meaning no new drug or device is being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to AI tools that help doctors choose the best treatment for each patient with acute respiratory failure.
What could go wrong: This is an early-stage observational study, not testing a treatment. The AI model may not work as hoped or may not apply to other hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE RESPIRATORY FAILURE

Contacts and locations

Locations

Samsung Medical Center
RECRUITING

Seoul, Gangnam, 06351, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.